179 related articles for article (PubMed ID: 23435142)
1. Characteristics and surgical outcome of HCC patients with low platelet count.
Kondo K; Chijiiwa Y; Otani K; Kai M; Ohuchida J; Chijiiwa K
Hepatogastroenterology; 2012 Oct; 59(119):2269-72. PubMed ID: 23435142
[TBL] [Abstract][Full Text] [Related]
2. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
3. The effect of postoperative TACE on prognosis of HCC with microscopic venous invasion.
Ke-Wei L; Tian-Fu W; Xi L; Lü-Nan Y; Bo L; Yong Z; Wu-Sheng L; Wen-Tao W; Ming-Qing X; Jia-Yin Y; Yu-Kui M; Zhe-Yu C
Hepatogastroenterology; 2012 Sep; 59(118):1944-6. PubMed ID: 22246191
[TBL] [Abstract][Full Text] [Related]
4. Preoperative transarterial chemoembolization for hepatocellular carcinoma.
Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
Hepatogastroenterology; 2012 Oct; 59(119):2295-9. PubMed ID: 23435144
[TBL] [Abstract][Full Text] [Related]
5. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
6. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
7. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
8. Safety of synchronous hepatectomy and splenectomy for patients with hepatocellular carcinoma and hypersplenism.
Wang C; Li C; Wen TF; Yan LN; Li B; Liang GL; Li KW
Hepatogastroenterology; 2012; 59(114):526-8. PubMed ID: 22353518
[TBL] [Abstract][Full Text] [Related]
9. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the clinical features of HCC following hepatectomy for different stages of HCC.
Ma C; Chi M; Su H; Cheng X; Chen L; Kan Y; Wei W; Huang X; Li Y; Li L; Lin K; Huang Y; Wu Y; Huang X; Huang A; Liu J
Hepatogastroenterology; 2012 Oct; 59(119):2104-11. PubMed ID: 23435129
[TBL] [Abstract][Full Text] [Related]
11. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
Zhang DZ; Wei XD; Wang XP
World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
[TBL] [Abstract][Full Text] [Related]
12. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of chemoembolization for recurrent HCC after curative ablation therapy.
Okabe N; Morimoto M; Kondo M; Moriya S; Numata K; Maeda S; Tanaka K
Hepatogastroenterology; 2013 May; 60(123):395-99. PubMed ID: 23108088
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
15. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
Zhang ZY; Zhou ZQ; Zhou GW
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1116-24. PubMed ID: 25003747
[TBL] [Abstract][Full Text] [Related]
16. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.
Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP
Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the role of nonanatomic resection of small (< or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function.
Kang CM; Choi GH; Kim DH; Choi SB; Kim KS; Choi JS; Lee WJ
J Surg Res; 2010 May; 160(1):81-9. PubMed ID: 19577249
[TBL] [Abstract][Full Text] [Related]
18. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
Hepatogastroenterology; 2015; 62(138):399-404. PubMed ID: 25916071
[TBL] [Abstract][Full Text] [Related]
20. Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited.
Chen YL; Ko CJ; Chien SY; Chen LS; Chen ML; Chi CW; Lai HW
J Gastroenterol Hepatol; 2011 May; 26(5):851-7. PubMed ID: 21129015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
